Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTAZIDIME Cause Respiratory failure? 77 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Respiratory failure have been filed in association with CEFTAZIDIME (TAZICEF). This represents 2.4% of all adverse event reports for CEFTAZIDIME.

77
Reports of Respiratory failure with CEFTAZIDIME
2.4%
of all CEFTAZIDIME reports
53
Deaths
67
Hospitalizations

How Dangerous Is Respiratory failure From CEFTAZIDIME?

Of the 77 reports, 53 (68.8%) resulted in death, 67 (87.0%) required hospitalization, and 38 (49.4%) were considered life-threatening.

Is Respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFTAZIDIME. However, 77 reports have been filed with the FAERS database.

What Other Side Effects Does CEFTAZIDIME Cause?

Drug ineffective (518) Off label use (266) Condition aggravated (228) Septic shock (200) Acute kidney injury (191) Pyrexia (176) Endophthalmitis (128) Multiple organ dysfunction syndrome (124) Neutropenia (123) Drug reaction with eosinophilia and systemic symptoms (121)

What Other Drugs Cause Respiratory failure?

PREDNISONE (2,299) CYCLOPHOSPHAMIDE (2,096) RITUXIMAB (1,838) TACROLIMUS (1,758) METHOTREXATE (1,685) DEXAMETHASONE (1,603) MYCOPHENOLATE MOFETIL (1,469) METHYLPREDNISOLONE (1,442) PREDNISOLONE (1,346) VINCRISTINE (1,120)

Which CEFTAZIDIME Alternatives Have Lower Respiratory failure Risk?

CEFTAZIDIME vs CEFTIBUTEN CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM CEFTAZIDIME vs CEFTRIAXONE CEFTAZIDIME vs CEFTRIAXONE\CEFTRIAXONE CEFTAZIDIME vs CEFUROXIME

Related Pages

CEFTAZIDIME Full Profile All Respiratory failure Reports All Drugs Causing Respiratory failure CEFTAZIDIME Demographics